IMMUNI T offers the full range of immunological services to support the drug development process from discovery to post-marketing.
IMMUNI T has developed significant expertise through experience in performing both standard and custom immuno-detection/diagnostic assays and assay validations.
IMMUNI T has certified state of the art equipment at its disposal such as multi-laser flow cytometers, radioactive plate counters, ligand binding platforms (ELISA, Luminex and MSD-ECL) and BSL2 (P2) cell culture facility with an expertise at working with primary material.
Our facility is located in Montreal, one of the major immunology hub in North America. For specific research projects, we also benefit from pro-active partnering resources with 4 universities and all major university hospitals within a 2 kilometers radius, with high technology equipment platforms and competent human resources, comprising Concordia University, McGill University, Université de Montréal and Université du Québec à Montréal.
Lower your risk, increase your value. Smart up your business and work with !
Luc Villeneuve, PhD, CEO
IMMUNI T is a contract research organization (CRO) providing high quality services in immunology and immunotoxicology with a core expertise in functional cell-based assays, flow cytometry and ligand-binding bioanalysis.
IMMUNI T performs cytotoxicty and other cell-based assays; ex vivo immunogenicity assays (cytokine release, proliferation), immunological assays based on flow cytometry analysis for determination of cell function, ligand-binding bioanalysis services for the quantification and detection of analytes including peptides, proteins or nucleic acids; as well as customization, development and validation of assays for pre-clinical and clinical sample analysis in a GLP-compliant environment.
IMMUNI T covers all your needs for biologics (peptides, proteins, therapeutic antibodies, biosimilars, vaccines and oligonucleotide-based therapeutics) in all phases of drug development programs.
Who We Are
High quality services in immunology: immuno-diagnostic/assays, cytokine detection, receptor binding, cell phenotyping, immunogenecity assessment and prediction, cell line characterization, ELISA and HL-ELISA.
Contract research services in:
Hematology and hemato-oncology
Vaccine efficacy and safety
Custom assay development and validation including primary and cell-line based assays for immuno-detection and diagnostic assays.
Special support for immunotherapeutics, immuno-modulation therapy and environmental immunotoxicology.
The following brochure provides a summary of the company and of the services IMMUNI T offers.
Zymeworks highly recommends IMMUNI T as a scientific CRO. IMMUNI T currently provides preclinical in vitro support for a variety of our bispecific and ADC programs and their technical expertise in the timely execution of complex experiments has been invaluable. They are a professional and highly organized team and their services would be an asset to any organization.
Candice Madalena, Senior Project Manager, Zymeworks Inc.
I have contracted IMMUNI T for several of our in vivo and ex vivo immunological studies over the years. I have always been very impressed and satisfied with their scientific knowledge, ability to accommodate our specific requests in a timely fashion and work ethics. I’m a big fan of their team and I strongly recommend IMMUNI T to anyone looking for a CRO with extensive immunological experience. They are the perfect partner for a small company like ours relying on external expertise.
Eric Zanelli, PhD
President and Scientific Founder Déclion Holdings LLC
Telephone : +1(514) 545 3097 ext 102
Telephone : +1(514) 545 3097 ext 115
5th floor, suite SB-5180
141 President-Kennedy Avenue ,
Montreal, Quebec, Canada H2X-1Y4
Telephone : +1(514) 545 3097
Fax : +1(514) 545 3064